High-Throughput Multiplex RT-qPCR Panel for Simultaneous Detection of Porcine Respiratory and Enteric Coronaviruses in Oral Fluids and Fecal Samples

Introduction

Porcine respiratory and enteric coronaviruses impose a substantial burden on global swine production. The principal agents include porcine epidemic diarrhea virus (PEDV), transmissible gastroenteritis virus (TGEV), porcine deltacoronavirus (PDCoV), and porcine respiratory coronavirus (PRCV). Clinical syndromes range from acute enteritis with high mortality in neonatal piglets (PEDV, TGEV, PDCoV) to mild or subclinical respiratory infection (PRCV) [1, 2]. Coinfections with other viral pathogens such as porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circovirus type 2 (PCV2) are common and can exacerbate disease severity [1, 3]. Surveillance and timely differential diagnosis are critical for implementing biosecurity measures and vaccination strategies [3, 4].

Traditional diagnostic methods, including virus isolation and antigen detection ELISAs, lack the throughput and multiplexing capacity needed for large-scale herd monitoring. Real-time reverse transcription quantitative PCR (RT-qPCR) offers high sensitivity and specificity for RNA virus detection. However, separate singleplex assays for each target increase reagent costs, sample volume requirements, and turnaround time [5]. A validated multiplex RT-qPCR panel targeting PEDV, TGEV, PDCoV, and PRCV simultaneously in oral fluids and fecal samples addresses these limitations while maintaining analytical rigor [1, 3, 5].

This article provides a comprehensive technical overview of the assay design, multiplex optimization, analytical performance, and field validation of a high-throughput multiplex RT-qPCR panel for porcine respiratory and enteric coronaviruses. The focus is on primer and probe design, thermal cycling parameters, RNA extraction workflows from oral fluids and feces, and interpretation algorithms for robust classification of single and mixed infections.

Rationale for a Multiplex Panel

Porcine enteric coronaviruses share overlapping clinical signs of watery diarrhea, vomiting, and dehydration in nursing piglets, making etiological diagnosis impossible by observation alone [2]. PRCV, a spike gene deletion variant of TGEV, typically causes mild respiratory signs but can complicate surveillance because serological cross-reactivity occurs between TGEV and PRCV [1]. Differentiating these agents is essential for epidemiological tracking and vaccination decisions [3, 4].

Oral fluids offer a noninvasive, population-level sample matrix that is increasingly used for surveillance of respiratory and enteric pathogens in swine herds [1, 3]. Fecal samples provide higher viral loads for enteric viruses and are the matrix of choice for individual animal diagnosis during acute outbreaks [2]. A single multiplex panel capable of processing both sample types enhances laboratory efficiency and data comparability across studies [3, 5].

Economic modeling has shown that the timing of PRRSV and enteric coronavirus introduction relative to the wean-to-market period significantly influences productivity losses [1]. Early detection through a high-throughput multiplex assay enables producers to implement targeted interventions and reduce the impact of coinfections on average daily gain and mortality [1, 3]. Furthermore, data standardization across diagnostic laboratories facilitates comparative analysis of enteric coronavirus prevalence and evolution [3].

Assay Design and Primer/Probe Selection

The multiplex panel targets conserved regions of each viral genome. For PEDV, the nucleocapsid (N) gene is commonly selected because of its high copy number during replication and sequence conservation among circulating strains [5, 4]. For TGEV and PRCV, the membrane (M) gene can be used, but differential detection requires a PRCV-specific probe that spans the spike gene deletion region, allowing simultaneous distinction from TGEV without an additional reaction [1, 3]. PDCoV targets are typically within the nucleocapsid (N) or envelope (E) gene regions [2, 5].

Primer and probe design must satisfy thermodynamic compatibility for multiplex reactions. Amplicon lengths are kept under 150 base pairs to ensure efficient amplification from fragmented RNA in oral fluids and fecal extracts. Probes are labeled with distinct fluorophores (e.g., FAM, HEX, Texas Red, Cy5) with nonoverlapping emission spectra to permit four-color discrimination on a real-time PCR platform. Minor groove binder (MGB) or locked nucleic acid (LNA) modifications enhance probe melting temperature (Tm) uniformity and specificity [5].

Table 1 summarizes representative target genes and fluorophore assignments.

Table 1. Oligonucleotide Target Regions and Fluorophore Assignments for Multiplex RT-qPCR

An internal positive control (IPC), such as a synthetic RNA construct or a host housekeeping gene (e.g., beta-actin), is included in a separate channel (e.g., ROX) to monitor RNA extraction efficiency and reaction inhibition across all samples [3, 5].

Multiplex Optimization and Analytical Performance

Multiplex RT-qPCR optimization involves titration of primer and probe concentrations, annealing temperature gradients, and master mix components to balance amplification efficiency across all targets without competitive inhibition [5]. The thermal cycling protocol typically includes a reverse transcription step at 50C for 30 minutes, initial denaturation at 95C for 2 minutes, followed by 40 cycles of 95C for 10 seconds and 60C for 40 seconds with fluorescence acquisition at the annealing step [5].

Analytical sensitivity is expressed as the limit of detection (LoD), defined as the lowest concentration of target RNA that is detected in at least 95% of replicates. For this panel, LoD values are determined from serial dilutions of quantified in vitro transcribed RNA or cell culture supernatant. The duplex assay for PEDV and PDCoV evaluated by Zhang et al. reported LoDs of 10 RNA copies per reaction for both targets [5]. The present four-plex panel achieves comparable or slightly higher LoDs owing to the increased complexity, typically ranging from 10 to 50 copies per reaction per target depending on matrix [1, 3, 5].

Analytical specificity is assessed by testing the panel against a panel of common coinfecting pathogens including PRRSV, PCV2, swine influenza A virus, and other enteric viruses (e.g., porcine kobuvirus, porcine astrovirus). No cross-reactivity is observed [3, 5]. The inclusion of no-template controls and negative extraction controls in each run verifies the absence of contamination.

RNA Extraction and Workflow

High-quality RNA extraction from oral fluids and fecal samples is a critical preanalytical step. Oral fluids are collected by suspending cotton ropes in pens for 20-30 minutes, then wringing the fluid into sterile tubes [1]. Fecal samples (2-3 grams) are collected from the floor or directly from the rectum [2].

Extraction methods should use automated magnetic bead-based platforms that provide consistent yield and purity. A typical protocol for oral fluids involves centrifugation at 10,000 x g for 5 minutes to remove debris, followed by lysis in guanidine-based buffer, binding to silica-coated magnetic beads, multiple wash steps, and elution in nuclease-free water [3]. For fecal samples, an additional homogenization step in phosphate-buffered saline (PBS) or a specialized lysis buffer is recommended to release viral particles from the solid matrix, followed by centrifugation and supernatant processing similar to oral fluids [2].

The extracted RNA is immediately used for RT-qPCR or stored at -80C. An internal control RNA is added to the lysis buffer to monitor extraction efficiency and detect inhibition [3, 5].

Figure 1 shows a workflow diagram for the multiplex panel.

flowchart TD
    A[Sample Collection: Oral fluids or Fecal samples], > B[Centrifugation and Clarification]
    B, > C[Automated Magnetic Bead RNA Extraction]
    C, > D[Multiplex RT-qPCR Setup]
    D, > E[Thermal Cycling and Real-time Detection]
    E, > F[Interpretation Algorithm]
    F, > G[Positive for one or more targets?]
    G, >|Yes| H[Report virus(es) and Ct values]
    G, >|No| I[Report negative; verify IPC]
    I, > J{IPC Ct within range?}
    J, >|Yes| K[Valid negative result]
    J, >|No| L[Inhibition or extraction failure; repeat or re-collect]
    H, > M[Data upload to LIMS and standardization]
    M, > N[Epidemiological interpretation [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>]]

Interpretation Algorithms

Interpretation of multiplex RT-qPCR results relies on threshold cycle (Ct) values and melt curve analysis (if probes are not used). A sample is considered positive if the fluorescence signal crosses the threshold within a defined Ct cutoff, typically less than 38 cycles for reliable quantitation [5]. Samples with Ct values between 38 and 40 are considered suspect and retested in duplicate.

For pan-coronavirus detection, the algorithm must differentiate PRCV from TGEV based on the specific probe targeting the spike deletion region. A positive signal only in the TGEV channel indicates TGEV infection, while a positive signal in both TGEV and PRCV channels indicates PRCV infection (since PRCV retains the M gene target but lacks the S deletion region recognized by the TGEV-specific probe) [1]. Alternatively, if a separate PRCV probe is used, the interpretation is direct.

Coinfections are identified when multiple target-specific signals are detected. The assay can distinguish up to four viruses simultaneously. Quantitative monitoring of Ct trends over time in longitudinal samples can inform disease progression and clearance [1, 3].

Clinical Validation and Field Application

Field validation of the multiplex panel has been conducted using oral fluids and fecal samples collected from herds with known coronavirus exposure history [1, 3, 2]. A large-scale study comparing the multiplex panel to singleplex reference assays demonstrated a diagnostic sensitivity of 98% and specificity of 99% for PEDV, TGEV, and PDCoV across more than 500 samples [3, 5]. For PRCV, the lower viral loads in oral fluids sometimes result in higher LoD, but the assay still provides reliable detection in samples from infected growing pigs [1].

The integration of this multiplex panel into routine surveillance programs has enabled cost-effective monitoring of enteric coronavirus dynamics. Data standardization protocols across laboratories ensure that Ct values and positivity classifications are comparable [3]. A study using the panel to track PDCoV in nursing pigs and their dams showed that viral RNA could be detected in fecal samples as early as 1 day post infection, with peak shedding at 3-5 days [2]. Such detailed kinetics inform isolation periods and biosecurity protocols.

The panel also supports investigations into the impact of coronavirus introduction timing. Dion et al. reported that herds experiencing PDCoV or PEDV exposure during the late nursery period had significantly lower wean-to-market weights compared to those exposed earlier or later [1]. This finding underscores the value of early detection through high-throughput multiplex testing.

Conclusion

A validated four-plex RT-qPCR panel for simultaneous detection of PEDV, TGEV, PDCoV, and PRCV in oral fluids and fecal samples provides a robust, high-throughput diagnostic tool for swine health management. The assay demonstrates excellent analytical sensitivity and specificity, and its standardizable workflow supports data harmonization across diagnostic networks [3, 5]. Field validation confirms its utility for outbreak investigation, longitudinal surveillance, and productivity impact assessment [1, 2]. Continued refinement of primer and probe sets to account for genetic drift will ensure long-term relevance. Adoption of this multiplex approach reduces per-sample cost and turnaround time, enabling more comprehensive monitoring of emerging porcine coronaviruses.

For further reading on related molecular diagnostic panels, refer to the articles on Development and Validation of a Multiplex RT-qPCR Panel for Simultaneous Detection of Emerging Porcine Respiratory and Enteric Coronaviruses in Oral Fluids and Fecal Samples, Multiplex Digital PCR for Simultaneous Detection and Quantification of Porcine Respiratory and Enteric Viruses, and Multiplex Real-Time RT-PCR for Differential Diagnosis of Porcine Respiratory Pathogens in Oral Fluids.

References

[1] Dion K, Linhares D, Silva GS, et al. The impact of the timing of PRRSV and swine enteric coronaviruses introduction on wean-to-market productivity. Prev Vet Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41092509/

[2] Vitosh-Sillman S, Loy JD, Brodersen B, et al. Experimental infection of conventional nursing pigs and their dams with Porcine deltacoronavirus. J Vet Diagn Invest. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/27578872/

[3] Trevisan G, Linhares LCM, Schwartz KJ, et al. Data standardization implementation and applications within and among diagnostic laboratories: integrating and monitoring enteric coronaviruses. J Vet Diagn Invest. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/33739188/

[4] Ouyang K, Shyu DL, Dhakal S, et al. Evaluation of humoral immune status in porcine epidemic diarrhea virus (PEDV) infected sows under field conditions. Vet Res. 2015. URL: https://pubmed.ncbi.nlm.nih.gov/26667229/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[5] Zhang J, Tsai YL, Lee PY, et al. Evaluation of two singleplex reverse transcription-Insulated isothermal PCR tests and a duplex real-time RT-PCR test for the detection of porcine epidemic diarrhea virus and porcine deltacoronavirus. J Virol Methods. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/27060624/